Skip to content

Clinical trials

Phase 3 Obesity trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Country / region: Spain Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20061
20072
20113
20131
20161
20172
20185
20214
20225
20238
20243
202515
202620

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting23
Active, not recruiting15
Terminated5
Not yet recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S21
Eli Lilly and Company19
Amgen5
Boehringer Ingelheim5
Sanofi5
Pfizer4
Rhythm Pharmaceuticals, Inc.4
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud2
Hoffmann-La Roche2
Kailera2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity73
Overweight35
Diabetes Mellitus, Type 212
Sleep Apnea, Obstructive7
Nutrition Disorders6
Body Weight4
Cardiovascular Diseases4
Diabetes Mellitus3
Osteoarthritis, Knee3
Overnutrition3

Trials

Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.